Acclinate, a trailblazer in advancing health equity through inclusive research, is thrilled to announce its win in the esteemed Diversity, Equity, & Inclusion category at the 3rd Annual Anthem Awards.
Birmingham, AL - January 30, 2024 – Acclinate, a trailblazer in advancing health equity through inclusive research, is thrilled to announce its win in the esteemed Diversity, Equity, & Inclusion category at the 3rd Annual Anthem Awards.
Hosted by the International Academy of Digital Arts and Sciences, the Anthem Awards brings together influential figures from various sectors to honor outstanding achievements in purpose-driven initiatives globally. Acclinate is honored to stand tall among impactful projects that are making a meaningful difference in our world.
At Acclinate, we take pride in our innovative approach, merging predictive analytics technology with empowered community building across diverse demographics. This distinctive strategy actively supports pharmaceutical companies in increasing representation in clinical trials while championing inclusivity in broader healthcare initiatives. Our mission is to transform trust and data into products that better serve communities of color.
Tiffany Whitlow, Chief Development Officer, and co-founder of Acclinate, expressed her gratitude, saying, "This accolade underscores our commitment to fostering diversity and health equity in clinical trials. From the beginning, we recognized the need to change the perception of healthcare, particularly concerning the care of minority communities."
As a winner, Acclinate stands among projects recognized for their game-changing impact in various causes, including Diversity; Equity & Inclusion; Education; Art & Culture; Health; Human & Civil Rights; Humanitarian Action & Services; Responsible Technology; and Sustainability, Environment & Climate.
Join us in celebrating this monumental achievement and get in touch to learn how Acclinate can support your diversity initiatives.